WHO DG holds talks with PM's Secy on partnership at Global Traditional Medicine Centre
Geneva: Director-General of the World Health Organization,
Tedros Adhanom Ghebreyesus
on Thursday (local time) held talks with
PK Mishra
, Principal Secretary to Prime Minister where they discussed their partnership on the
WHO
Global Traditional Medicine Centre
, outposted in
Jamnagar
.
Ghebreyesus thanked Mishra for India's leadership on the Pandemic Accord adoption, and support of increased assessed contributions to WHO's work to advance health for all.
"Had good meeting with P.K. Mishra, Principal Secretary to PMO India, on the many areas of close collaboration between WHO and India. We discussed our partnership on the WHO Global Traditional Medicine Centre, outposted in Jamnagar, which will help the world benefit from the potential of traditional medicine and complement modern approaches to health.
I thanked Dr Mishra for India's leadership on the Pandemic Accord adoption, and support of increased assessed contributions to WHO's work to advance Health for All. I also commended India for its investment in health care infrastructure, the "
Ayushman Bharat
" scheme to expand universal health coverage, and in digital health."
Mishra also held talks with Hara Hiroaki, Vice-Minister for Policy Coordination of Japan, on margins of Global Platform for
Disaster Risk Reduction
2025.
In a post on X, the Indian Permanent Mission at Geneva stated, "Fruitful discussions between Principal Secretary to PM Dr. P.K Mishra and Mr. Hara Hiroaki, Vice-Minister for Policy Coordination of Japan, on margins of GPDRR 2025. Explored enhanced India-Japan collaboration on disaster resilience and exchanging expertise in risk reduction strategies."
Mishra also held talks on disaster preparedness with Major General Ariunbuyan Gombojav, Chief of National Emergency Management Agency of Mongolia, on the sidelines of GPDRR 2025.
"Principal Secretary to PM Dr. P.K Mishra meets with Major General Ariunbuyan Gombojav, Chief of National Emergency Management Agency of Mongolia, on the sidelines of GPDRR 2025. Valuable exchange on disaster preparedness strategies and exploring opportunities for India-Mongolia cooperation in DRR."
Mishra also held talks with Head of UNDRR Kamal Kishore on strengthening India's disaster risk reduction partnerships and advancing global resilience frameworks.
Meanwhile, BIMSTEC countries convened at the High-Level UNDRR-BIMSTEC event on the margins of GPDRR 2025 in Geneva. India's head of delegation to GPDRR, Principal Secretary to PM PK Mishra, highlighted the role of the BIMSTEC Centre for Disaster Management, as announced by PM Narendra Modi at the 6th BIMSTEC Summit, to accelerate the region's implementation of the Sendai Framework.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
India.com
3 hours ago
- India.com
COVID-19 Cases In India: Active Cases Rise To 5,364; Delhi 592 - Kerala Leading With 1,679 Cases; 4 Deaths In 24 Hours
COVID 19 Cases Rising In India Live Updates: India is once again witnessing an unsettling rise in COVID-19 cases, with the number of active infections climbing to 5,364; according to the Ministry of Health and Family Welfare's latest update as of 8:00 AM IST, June 7, 2025. Leading the current spike is Kerala, with 192 fresh infections, pushing its active caseload to 1,679; nearly half of the country's total. Meanwhile, West Bengal added 58 new cases, increasing its active tally to 596, while the national capital Delhi, recorded 30 new infections, taking its active cases to 592. Maharashtra, another state that has seen consistent rises in previous waves, reported 22 new COVID-19 cases, bringing the total number of infections recorded to 548, as per the state's public health department. As per May 2025 classifications by the World Health Organization (WHO), subvariants LF.7 and NB.1.8.1 are categorized as Variants Under Monitoring, meaning they are not yet deemed as Variants of Concern or Variants of Interest. However, these strains are suspected to be contributing to the rising infections not just in India but also across China and other parts of Asia. Despite the emergence of new subvariants, the JN.1 strain remains the most dominant, accounting for a staggering 53% of all positive cases across the country. According to data from the Indian SARS-CoV-2 Genomics Consortium (INSACOG), a case of NB.1.8.1 was detected in Tamil Nadu in April, while four cases of LF.7 were identified in Gujarat earlier this month. With the virus subtly shifting form and symptoms evolving, health authorities are urging the public to maintain precautionary measures, including hygiene, mask use in crowded places, and timely testing. Although hospitalisation remains low, experts warn that complacency could reverse progress. Stay informed, and if you're experiencing mild symptoms like fatigue, a sore throat, or gastrointestinal discomfort, it's best to test early and isolate to prevent further spread. Say Tuned To Zee News For Latest Updates...
Hindustan Times
4 hours ago
- Hindustan Times
As Covid-19 cases in India cross 5,000-mark, states issue advisories
As Covid-19 cases across India crossed the 5,000 mark on Friday, states began issuing advisories, while the Centre conducted mock drills to assess facility-level preparedness. India currently has 5,364 active Covid-19 cases, with four new deaths reported in the past 24 hours as of Friday. According to data from the Union health ministry, Kerala remains the worst-affected state, followed by Gujarat, West Bengal, and Delhi. In the last 24 hours, Kerala reported 192 new cases, Gujarat 107, West Bengal 58, and Delhi 30, contributing to a nationwide spike of 498 new infections. In Delhi, 30 new Covid-19 infections were reported, bringing the number of active cases to 592. The capital has recorded seven deaths since January 1, with no new fatalities reported since Thursday. The Centre has directed all states to ensure the availability of oxygen, isolation beds, ventilators, and essential medicines in light of the rising number of Covid-19 cases. Maharashtra reported 114 new Covid-19 cases, raising the total to 1,276 since January this year, the state health department said on Friday. One additional fatality was reported, taking the death toll to 18. Of these, 17 patients had comorbidities (simultaneous presence of two or more medical conditions), the department added. Haryana recorded 31 new cases, with 20 from Gurugram and Faridabad districts, news agency PTI reported quoting officials. Gurugram reported nine cases, while Faridabad recorded 11 cases. Other districts included Karnal and Jhajjar with three cases each, Panipat with two cases, and Yamunanagar, Hisar, and Panchkula with one case each. The state reported 87 active cases on Friday, with a total of 151 cumulative positive cases. Only two patients are currently admitted to health facilities. Haryana health minister Arti Singh Rao urged people and healthcare officials to remain vigilant: "Timely action and strict adherence to preventive measures can significantly curb the spread of the virus," she said. "There is no need to panic." Seven new COVID-19 cases were reported in Odisha, bringing the total infections in the current wave to 30, a senior health officer said on Friday. State public health director Nilakantha Mishra said that seven people have recovered so far. The state currently has 23 active cases, none of which are serious. 'On average, five to seven new cases are being detected every day. We are holding discussions with officers concerned at the Centre for issuance of an advisory to the people,' Mishra said. State health services director Amarendra Nath Mohanty advised: 'People with COVID-19 symptoms should not visit Puri during the upcoming Rath Yatra later this month. Such persons can witness the festival through television and other media platforms,' he said. At present, testing is focused on hospitalised patients, with a test positivity rate of 1 to 1.5 per cent. "However, we all have to remain cautious," Mishra added. On Thursday, the Odisha government indicated that preventive measures may be introduced in schools when they reopen on June 20 after the summer vacation. School and mass education minister Nityananda Gond said: 'Students with COVID-like symptoms would be asked to wear masks in schools, while those with more acute signs of the infection would be asked to stay home and isolate themselves.' In West Bengal, 58 new COVID-19 cases were detected in the last 24 hours, the ministry of health and family welfare said on Friday. During the same period, 91 patients recovered, bringing the total number of active cases to 596. The death toll remained unchanged at one. Officials said, 'The situation is under control, and there is nothing to worry about. However, we would advise the people to follow the COVID-19 health-related protocols and wear masks.' (With ANI, PTI inputs)
Indian Express
4 hours ago
- Indian Express
Measles spike in US shows how vaccine hesitancy threatens decades of public-health progress
Vaccines are critical tools for the containment and elimination of infectious diseases. They work not merely by protecting individuals, but by reducing community transmission. There have been several global pushes to improve vaccine uptake over the years, but one major coordinated effort occurred in 2021 in response to the Covid pandemic, which saw the most rapid vaccine introduction in history. Globally, the years with the most vaccine introductions have typically coincided with public health initiatives, funding boosts, or as a response to pandemics. The 1980s and 1990s saw WHO's Expanded Programme on Immunisation (EPI) with DTP (diphtheria-tetanus-pertussis), polio, measles, BCG (tuberculosis) vaccines and Hepatitis B and Hib vaccines introduced in the late 1990s. The 2000s saw accelerated introductions of Hepatitis B, Haemophilus influenzae type B (Hib), and yellow fever vaccines in low-income countries, marking a shift in global access to routine vaccines. The introduction of new and underused vaccines like pneumococcal conjugate vaccine (PCV), rotavirus vaccine, HPV and Measles-Rubella (MR) vaccine marked the next decade. The United States is currently experiencing a significant resurgence of measles, with 1,046 confirmed cases as of May 27. This marks a sharp increase from previous years, with the majority of cases occurring among unvaccinated individuals in regions with declining immunisation rates. Measles was officially eliminated from the US in 2000. This implies that new cases occur only when someone contracts measles abroad and returns to the country. A new study from Johns Hopkins points out that the significant drop in childhood vaccination rates is concerning because herd immunity requires at least 95 per cent vaccination coverage. The MMR vaccine is probably one of the most effective vaccines. A single dose gives 93 per cent protection from infection, and two doses up to 98 per cent. Measles, which can be deadly for unvaccinated children, is highly contagious. Factors like post-pandemic vaccine hesitancy, non-evidence-based fears of the association between the MMR vaccine and autism, and the complacency of populations who may not remember the long-term sequelae of measles infection are behind the dwindling measles vaccination rates in the US. Measles is often regarded as the 'canary in the coalmine' — if cases spread, it is a warning that other disease outbreaks might spring up where there are gaps in vaccination coverage. Its resurgence in the US is a global warning that even advanced health systems are vulnerable without consistent immunisation. Globally, only 83 per cent of children received the first dose of the measles vaccine in 2023; 74 per cent received the second dose. These figures fall short of the 95 per cent coverage needed to prevent outbreaks. India has made significant strides in its immunisation efforts, particularly under the UIP. India achieved a national immunisation coverage of 93.5 per cent in 2023–24, indicating that the majority of children received all recommended vaccines by the age of two. Since its inception, Mission Indradhanush, focused on areas with low immunisation rates, has completed 12 phases, vaccinating 5.46 crore children and 1.32 crore pregnant women across 554 districts. However, the measles upsurge in the US shows one cannot ignore increasing vaccine hesitancy, particularly since it threatens to throw away the gains made in the containment of infectious diseases. In resource-limited settings, this can lead to healthcare systems being overwhelmed and a general delay in uptake of new vaccines. Misinformation has contributed significantly to the declining uptake for vaccines. The flu vaccination rates among NHS staff in the UK, for instance, dropped to their lowest in nearly 15 years in 2024-25. So far, India has remained immune to vaccine hesitancy. Previous experience with successful vaccination campaigns and government endorsements have played an important role in creating a positive perception of vaccines. However, we must remain alert and actively consider putting in place a multi-pronged, culturally nuanced plan to address vaccine hesitancy. The writer is senior scientist, ICMR
